Publisher
source

Greta Hultqvist

Just Landed

Posted Yesterday

Postdoctoral Position in AAV-Based Biopharmaceutical Therapies for Alzheimer’s and Neurodegenerative Diseases Uppsala University in Sweden

Degree Level

Postdoc

Field of study

Molecular Biology

Funding

Available

Deadline

Nov 16, 2026

Country flag

Country

Sweden

University

Uppsala University

Apply for this position

Keywords

Molecular Biology
Biomedical Engineering
Biotechnology
Biology
Alzheimer's Disease
Neuropsychology
Medical Science
Pharmacy
Biopharmaceutics
Pharmaceutical Chemistry
Neurodegenerative Disease

Suggested positions

Publisher
source

The University of British Columbia

Country flag

Canada

Postdoctoral Research Fellow position at the University of British Columbia (UBC), Vancouver Campus, in the Faculty of Pharmaceutical Sciences / Kumar Lab under Dr. Ujendra Kumar . The project focuses on neuroscience and medical science topics including excitotoxicity , neurodegenerative disease models , and Alzheimer’s disease . Research activities include validating biomarkers, testing small-molecule therapeutics in animal models, and evaluating the neuroprotective and behavioral effects of ca...

Biology
Alzheimer's Disease
Neuropsychology
+4 more

2 weeks ago

Publisher
source

Antonios Pantazis

Linköping University

Country flag

Sweden

Linköping University is advertising a 3-year, fully funded postdoc in the Pantazis lab focused on novel ion-channel engineering . The project aims to build new ion-channel prototypes and develop tools that may shape the future of research and medical electrophysiology . This opportunity is especially relevant for candidates with interests in electrophysiology , ion channels , molecular physiology , and related biomedical engineering approaches. The post explicitly encourages applicants who are c...

Molecular Biology
Biomedical Engineering
Biology
+2 more

2 weeks ago

Publisher
source

Lidia Wrobel

International Institute of Molecular and Cell Biology in Warsaw

Country flag

Poland

Postdoctoral Researcher opportunity in Warsaw, Poland at the Laboratory of Cellular Proteostasis, IIMCB (Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie). The project focuses on nuclear protein quality control and its relevance to neurodegeneration . The research program combines molecular biology , cell biology , human iPSC-derived neurons , and disease models to address fundamental questions in proteostasis and neuronal disease mechanisms. The post is suitable for a rese...

Cell Biology
Molecular Biology
Biomedical Engineering
+5 more

1 week ago

Publisher
source

Łukasiewicz Research Network – PORT Polish Center for Technology Development

Country flag

Poland

Postdoctoral Fellow in Neurodegeneration at the P4Health Center of Excellence in Precise Phenotyping and BioDataBanking for Personalised Brain Health, hosted by Łukasiewicz Research Network – PORT Polish Center for Technology Development in Wrocław, Poland. This postdoctoral opportunity is part of the P4Health CoE, an interdisciplinary initiative advancing Predictive, Preventive, Personalized, and Participatory (P4) medicine. The project is carried out within the MAB/IRA programme of the Foundat...

Molecular Biology
Biomedical Engineering
Biology
+8 more

3 weeks ago

Publisher
source

The University of Hong Kong

Country flag

Hong Kong

The University of Hong Kong invites applications for a Postdoctoral Fellow in LNP-Assisted Gene Editing for Neurodegeneration in the JC STEM Lab of Nanomedicine for Advanced Therapy, Department of Pharmacology and Pharmacy, led by Professor Khuloud Al-Jamal. The project develops lipid nanoparticle (LNP)-based CRISPR-Cas9 gene-editing platforms for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The postdoctoral fellow will design and evaluate single and dual gene-knockout ...

Molecular Biology
Biomedical Engineering
Biology
+8 more

6 days ago

About this position

Uppsala University is recruiting a full-time postdoctoral researcher in biopharmaceuticals at the Department of Pharmacy in Uppsala, Sweden. The two-year temporary position focuses on developing AAV-based therapies for Alzheimer’s disease and other neurodegenerative disorders, with a starting date of 1 February 2027 or by agreement.

The research group develops biologic therapies for Alzheimer’s disease and Parkinson’s disease using protein-based, antibody-based, and AAV gene-therapy approaches. The postdoctoral researcher will design, produce, purify, and characterize AAV vectors and evaluate therapeutic strategies through in vitro and in vivo experiments. Biopharmaceutical design, molecular cloning, sterile cell culture, animal studies, and translational neuroscience research will be central components. Teaching and administrative duties may also be included.

Applicants must have, or obtain by the employment decision, a PhD in molecular biology, biotechnology, gene therapy, neuroscience, or a related discipline, together with experimental experience in molecular biology, gene therapy, biologics, or a related field. Candidates must be willing to work with animal experiments. Experience with AAV vector engineering, purification, ÄKTA systems, cell culture, ELISA, flow cytometry/FACS, in vivo studies, neurodegenerative diseases, or teaching will be advantageous.

The application deadline is 16 November 2026. Applications should be submitted through Uppsala University’s recruitment system, including answers to the selection questions that replace a cover letter. For further information, contact Professor Greta Hultqvist at [email protected].

Funding details

Available

What's required

Applicants must hold a PhD in a relevant field such as molecular biology, biotechnology, gene therapy, neuroscience, or a related discipline by the employment decision. Priority is given to candidates who obtained the degree no more than three years before the application deadline, subject to possible extensions for circumstances such as sick leave or parental leave. Experience in experimental molecular biology, gene therapy, biologics, or a related field is required. Candidates must be willing to conduct animal experiments. Preferred experience includes AAV vector design and optimization, AAV production, purification and characterization, molecular cloning, expression-vector construction, gene-therapy strategy development, AAV or protein purification using systems such as ÄKTA, sterile cell culture, ELISA, flow cytometry/FACS, in vivo experiments, neurodegenerative disease research, and teaching. Applicants should be curious, creative, motivated, able to work independently, take initiative, communicate effectively, collaborate well, and contribute to a positive research environment.

How to apply

Submit your application through Uppsala University’s recruitment system via the direct application link. Answer the questions provided in the application; a cover letter is not required. Apply by 16 November 2026 and cite reference UFV-PA 2026/3107.

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts and confirm requirements with the university.

Professors

Professor

University Name
Country flag

Sweden

Research Interests

Immunology

Neurology

Neuroprotection

Alzheimer's Disease

Antibodies